University Hospital Tuebingen
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicity
Completed
- Conditions
- Malaria Transmission
- Interventions
- Other: Pre-treatment follow upOther: Post treatment follow upOther: S. haematobium treatmentOther: Olfactometer experiment
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 380
- Registration Number
- NCT02769013
- Locations
- 🇬🇭
KCCR, Kumasi, Ghana
🇬🇦Ayôla Akim ADEGNIKA, Lambarene, Albert Schweitzer Hospital, Gabon
Physiological Response and Visual Attention to Visual Food Images in Healthy Subjects and in Functional Dyspepsia Patients
Not Applicable
Completed
- Conditions
- Functional Dyspepsia
- Interventions
- Behavioral: visual images
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 30
- Registration Number
- NCT02727556
- Locations
- 🇩🇪
Psychosomatic Medicine and Psychotherapy Department, University of Tübingen, Tübingen, Germany, Tübingen, Germany
Study of MR-based IGRT for Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Radiation: IGRT
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 78
- Registration Number
- NCT02724670
- Locations
- 🇩🇪
Müller Arndt-Christian, Tübingen, Germany
Investigation of Desmoplastic Squamous Cell Carcinoma
Not Applicable
- Conditions
- Squamous Cell Carcinoma of the Skin
- Interventions
- Procedure: Immunohistochemistry using Pancytokeratin Staining
- First Posted Date
- 2016-03-24
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 73
- Registration Number
- NCT02717936
- Locations
- 🇩🇪
Universityhospital, Tübingen, Baden-Württemberg, Germany
Inflammatory Mediators in Early Sepsis
- Conditions
- Inflammation
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2021-06-07
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 60
- Registration Number
- NCT02692118
- Locations
- 🇩🇪
University Hospital Tuebingen, Tuebingen, Germany
Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation
Not Applicable
Completed
- Conditions
- SchizophreniaAuditory Hallucinations
- Interventions
- Device: MagPro Cool-B65A/P, Magventure
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 138
- Registration Number
- NCT02670291
- Locations
- 🇩🇪
Department of Psychiatry and Psychotherapy, Tuebingen, Germany
Compliance of Clinical Pathways in Elective Laparoscopic Cholecystectomy: Evaluation of Different Implementation Methods
Completed
- Conditions
- Gallstones
- Interventions
- Other: clinical pathway
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 241
- Registration Number
- NCT02667249
Personalised Postoperative Radiochemotherapy in Patients With Head and Neck Cancer
Not Applicable
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Radiation: Integration of PET/MRI in radiotherapy
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 49
- Registration Number
- NCT02666885
- Locations
- 🇩🇪
University Hospital Tübingen, Department of Radiation Oncology, Tübingen, Baden-Württemberg, Germany
Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted
Phase 1
Completed
- Conditions
- Malaria, Antepartum
- Interventions
- Biological: PAMVACOther: PlaceboBiological: GLA-SEBiological: GLA-LSQBiological: Alhydrogel
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 66
- Registration Number
- NCT02647489
- Locations
- 🇧🇯
Institut de Recherche Clinique du Benin (IRCB), Abomey-Calavi, Benin
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2015-12-30
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 300
- Registration Number
- NCT02642458
- Locations
- 🇩🇪
Hochschulklinikum der Med. Hochschule Brandenburg, Neuruppin, Brandenburg, Germany
🇩🇪St. Vicentius Kliniken Karlsruhe gAG Frauenklininik, Karlsruhe, Baden-Württemberg, Germany
🇩🇪Klinikum Mannheim, Universitäts-Frauenklinik, Mannheim, Baden-Württemberg, Germany
© Copyright 2025. All Rights Reserved by MedPath